Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05187624
Title A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ESP | DNK | CAN | AUS

Facility Status City State Zip Country Details
UCLA Neuro-Oncology Program Los Angeles California 90095 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering Cancer Center New York New York 11101 United States Details
Peter MacCallum Cancer Centre; Medical Oncology Melbourne Victoria 3000 Australia Details
Princess Margaret Cancer Center Toronto Ontario M5G 1Z5 Canada Details
Rigshospitalet, Onkologisk Klinik; Klinisk Forskningsenhed København Ø 2100 Denmark Details
Amsterdam UMC Location VUMC Amsterdam 1081 HV Netherlands Details
Clinica Universitaria de Navarra Pamplona Navarra 31008 Spain Details
Vall d?Hebron Institute of Oncology (VHIO), Barcelona Barcelona 08035 Spain Details
Clinica Universidad de Navarra Madrid; Servicio de Oncología Madrid 28027 Spain Details
START Madrid-FJD, Hospital Fundacion Jimenez Diaz Madrid 28040 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field